Adhikari Vijayendra, Sitaula Prasamsha, Thapa Ojas, Singh Sumi, Mishra Anil Kumar, Singh Ramesh Prasad, Chalise Pralhad Kumar, Shrestha Praphulla
Department of Orthopaedics, Nepal Medical College and Teaching Hospital, Jorpati, Kathmandu, Nepal.
Nepal Medical College and Teaching Hospital, Jorpati, Kathmandu, Nepal.
JNMA J Nepal Med Assoc. 2024 Apr 30;62(273):297-300. doi: 10.31729/jnma.8571.
There is a high incidence of open fractures accounting 23% of all tibial fractures. The minimal soft tissue and precarious blood supply of the shaft of tibia make these fractures vulnerable to complications. The treatment should be decided through thoughtful analysis for personality of injuries and the status of the soft tissue. Intramedullary nailing allows stable fixation with minimal soft tissues dissection and preserve the soft tissue and allows early joint motion with higher rate of union. The purpose of our study was to find the outcome of open tibial fractures lower than Gustilo type IIIb, that were treated by unreamed solid interlocking intramedullary nails.
A descriptive cross-ectional study was conducted from December 2021 to June 2023 after taking approval from ethical committee. All 34 patients treated with solid interlocking intramedullary nail, without reaming for open tibial fracture during 18 months period were included in the study. Final follow up was done at one year and the outcome was assessed by Modified Ketenjian's criteria.
The mean time of union rate was 15.82±3.95 weeks. Complications were: superficial infections in 4 (11.76%) patients and deep infection in 1 (2.94%) patient. Using Modified Ketenjian's Criteria, 26 (76.47%) patients had an excellent result followed by good in 7 (20.59%), fair in 1 (2.94%) and there was no case with poor outcome.
Solid intramedullary interlocking nail is an effective treatment with minimal soft tissue dissection for open tibia fracture less than GA III B as it provides stable fixation with early mobilization and provides a high rate of union, less complication and early return to function.
开放性骨折的发生率较高,占所有胫骨骨折的23%。胫骨骨干软组织最少且血供不稳定,使得这些骨折易发生并发症。治疗应通过对损伤特点和软组织状况的深入分析来决定。髓内钉固定能够在软组织剥离最少的情况下实现稳定固定,保护软组织,并允许早期关节活动,愈合率更高。我们研究的目的是探讨采用非扩髓实心交锁髓内钉治疗低于Gustilo IIIb型的开放性胫骨骨折的疗效。
在获得伦理委员会批准后,于2021年12月至2023年6月进行了一项描述性横断面研究。纳入在18个月期间接受实心交锁髓内钉治疗且未扩髓的34例开放性胫骨骨折患者。在1年时进行最终随访,并采用改良的Ketenjian标准评估疗效。
平均愈合时间为15.82±3.95周。并发症包括:4例(11.76%)患者发生浅表感染,1例(2.94%)患者发生深部感染。根据改良的Ketenjian标准,26例(76.47%)患者疗效优秀;7例(20.59%)患者疗效良好;1例(2.94%)患者疗效尚可;无疗效差的病例。
实心交锁髓内钉是治疗低于GA III B型的开放性胫骨骨折的有效方法,软组织剥离最少,因为它能提供稳定固定、早期活动,愈合率高,并发症少,且能早期恢复功能。